Research Article
Evaluation of Medication Package Inserts in Ethiopia
Table 3
Presence of safety-related information on medication package inserts (nā=ā200).
| Variables | Frequency | Percentage |
| Adverse drug reactions | 191 | 95.5 | Contraindications | 189 | 94.5 | Drug-drug interactions | 160 | 80.0 | Drug-food interactions | 42 | 21.0 | Pregnancy considerations | 154 | 77.0 | Lactation considerations | 148 | 74.0 | Pediatric considerations | 141 | 70.5 | Geriatric considerations | 75 | 37.5 | Special warning and precautions | 99 | 49.5 | Abuse/dependence property | 7 | 3.5 | Effect on the ability to drive and operate machines | 69 | 34.5 | Overdose and management | 139 | 69.5 | Maximum dose | 54 | 27.0 | Missing dose | 52 | 26.0 | Handling and disposal | 45 | 22.5 |
|
|
Example: renal, hepatic, cardiac, or nutritional insufficiencies that require either increased or reduced dosage. |